# Long Term Follow-up on Menkes Disease Patients

> **NCT04337684** · — · ACTIVE_NOT_RECRUITING · sponsor: **Sentynl Therapeutics, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Menkes Disease

## Interventions

- **DRUG:** Long Term Follow-Up

## Key facts

- **NCT ID:** NCT04337684
- **Lead sponsor:** Sentynl Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-01
- **Primary completion:** 2026-02-26
- **Final completion:** 2026-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04337684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04337684, "Long Term Follow-up on Menkes Disease Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04337684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*